Table 1. Patient characteristics and outcomes.
| Study cohort % (n/N), unless otherwise stated | All patients admitted to the department % (n/N), unless otherwise stated | |
|---|---|---|
| Age (years), median (IQR) | 70 (57–82) | 65 (54–78) |
| Female | 43% (54/126) | 42% (87/206) |
| Diagnosis of COVID-19 confirmed by PCR | 90% (114/126) | 89% (184/206) |
| BMI ≥30 | 42% (38/91) | 40% (56/141) |
| CACI ≥4 | 50% (63/126) | 43% (88/206) |
| No-ICU-decision documented | 48% (60/126) | 37% (77/206) |
| Red NEWS-2 [29] parameter on first measurements of vital signs | ||
| SpO2 (≤91%) | 27% (34/126) | 28% (57/206) |
| Respiratory rate (≤8 or ≥25 breaths/min) | 54% (68/126) | 49% (100/203) |
| Heart rate (≤40 or ≥131 beats/min) | 3.2% (4/125) | 2.4% (5/205) |
| Systolic blood pressure (≤90 or ≥220 mmHg) | 2.4% (3/125) | 2.0% (4/205) |
| Consciousness (Non-alert) | 13% (17/126) | 10% (20/204) |
| Temperature (≤35.0 or ≥39.1°C) | 14% (18/125) | 16% (32/205) |
| Treatments during hospital-stay | ||
| Antibiotics | 79% (99/126) | 77% (158/206) |
| Chloroquine | 12% (15/126) | 14% (28/206) |
| Anticoagulants | 52% (65/126) | 55% (114/206) |
| Patient outcomes | ||
| Length of stay (days), median (IQR) | 4.9 (2.8–7.8) | 4.3 (2.2–9.0) |
| Transfer to another department | 6.4% (8/126) | 13% (27/206) |
| Dead in-hospital | 26% (33/126) | 19% (40/206) |
| Dead at 60 days | 32% (40/126) | 23% (48/206) |
*Abbreviations: PCR: Polymerase chain reaction, BMI: Body mass index, CACI: Charlson´s age adjusted comorbidity score, ICU: Intensive care unit, SpO2: Peripheral oxygen saturation.